Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

F. Cappuzzo
  • Annals of Oncology, June 2006, Oxford University Press (OUP)
  • DOI: 10.1093/annonc/mdl077

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1093/annonc/mdl077

The following have contributed to this page: Dr Federico Cappuzzo and Dr. Rocco Trisolini